PDCD1 and neoplasm: Based on this observation, we used the MC38 tumor model, which is respond to anti-PD-1 therapy, and the CT26 tumor model, which is not respond to anti-PD-1 therapy and examined combination therapy using anti-PD-1 and CU06-1004.